Beryl Capital Management’s MoonLake Immunotherapeutics MLTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-459,243	Closed	-$5.1M	–	60
2022 Q1	$5.1M	Buy	+459,243	New	+$5.1M	0.31%	129